表紙:マルチプレックスアッセイ(分子多重化)の世界市場:COVID-19の潜在的な影響に関する考察と予測:2020年-2024年
市場調査レポート
商品コード
948343

マルチプレックスアッセイ(分子多重化)の世界市場:COVID-19の潜在的な影響に関する考察と予測:2020年-2024年

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版日: | 発行: Koncept Analytics | ページ情報: 英文 117 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
マルチプレックスアッセイ(分子多重化)の世界市場:COVID-19の潜在的な影響に関する考察と予測:2020年-2024年
出版日: 2020年07月09日
発行: Koncept Analytics
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマルチプレックスアッセイ市場は、2020年から2024年まで7.18%のCAGRで拡大し、2024年には48億7,000万米ドルに達すると予測されています。市場拡大の原動力となるのは、HIV感染症の有病率上昇、新規がん患者の症例増加、医療技術の研究開発に対する支出の増加、高齢者人口の増加、 医療費の急増、創薬分野でのマルチプレックスイムノアッセイの利用拡大、コンパニオン診断の普及拡大、製薬業界とバイオテクノロジー業界での合併と買収、自己免疫疾患分野でのバイオシミラーの動き、多重ポイントオブケア検査(xPOCT)の需要拡大などの要因です。

当レポートは、世界のマルチプレックスアッセイ市場を調査したもので、新型コロナウイルス感染症(COVID-19)パンデミックの影響、世界市場と各地域市場の分析、市場の力学、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 概要

  • イントロダクション
  • 従来のアッセイとマルチプレックスアッセイの違い
  • 分子多重化成功の要因
  • 多重化プラットフォーム
  • マルチプレックスアッセイの将来像

第2章 COVID-19の影響

  • COVID-19検査の増加
  • 各国政府の医療費支出増加
  • 医療分野における人工知能の導入拡大
  • 地域的な影響

第3章 世界市場の分析

  • 金額ベースの市場
  • 金額ベースの市場予測
  • 製品別市場
    • 消耗品
    • 機器
    • ソフトウェア
  • 用途別市場
    • 研究開発
    • 臨床診断市場
    • コンパニオン診断
  • エンドユーザー別市場
    • 製薬会社とバイオテクノロジー企業
    • 研究機関
    • 臨床検査室
    • 病院
  • 地域別市場

第4章 地域市場の分析

  • 北米
  • アジア太平洋
  • 欧州
  • ラテンアメリカ
  • 中東・アフリカ

第5章 市場の力学

  • 成長促進要因
    • HIV感染症の有病率上昇
    • 新規がん患者の症例増加
    • 医療技術研究開発費の増加
    • 高齢者人口の増加
    • 医療費の急増
    • 創薬分野でのマルチプレックスイムノアッセイの利用拡大
    • コンパニオン診断の普及拡大
  • 主なトレンドと動き
    • 感染症の発症率上昇
    • 製薬業界とバイオテクノロジー業界での合併と買収の増加
    • 自己免疫疾患の分野におけるバイオシミラーの動き
    • 多重ポイントオブケア検査(xPOCT)の需要
  • 課題
    • 熟練した専門家の不足
    • 多額の投資資本
    • 各国政府の厳格な規制

第6章 競合情勢

  • 世界の市場
    • 主要企業の収益比較
    • 主要企業の研究開発支出の比較
    • 主要企業の時価総額の比較

第7章 企業プロファイル

  • Thermo Fisher Scientific
    • 財務概要
    • 財務概要
    • 事業戦略
  • Becton, Dickinson and Company (BD)
    • 財務概要
    • 財務概要
    • 事業戦略
  • BioMerieux
    • 事業の概要
    • 財務概要
    • 事業戦略
  • Bio-Rad Laboratories
    • 事業の概要
    • 財務概要
    • 事業戦略
  • Qiagen
    • 事業の概要
    • 財務概要
    • 事業戦略
  • Luminex Corporation
    • 事業の概要
    • 財務概要
    • 事業戦略
図表

List of Tables

  • Determinants of Successful Molecular Multiplexing
  • Multiplexing Platforms
  • COVID-19 Test per Million Population
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
目次

The global multiplex assays market is expected to reach US$4.87 billion in 2024, increasing at a CAGR of 7.18%, for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV, rising incidences of cancer cases, increasing medical technology R&D spending, growth in geriatric population, upsurge in healthcare expenditures, rise of multiplex immunoassays in drug discovery and escalating adoption of companion diagnostics would drive the growth of the market. However, the market growth would be challenged by dearth of skilled professionals, high investment capital for multiplex assays and stringent government regulations. A few notable trends may include accelerating growth rates of infectious diseases, growth in pharmaceutical and biotech merger & acquisition, monitoring of biosimilar in autoimmune diseases and demand for multiplexed point-of-care tests (xPOCT).

The global multiplex assays market has been segmented into consumables, instruments and software, based on product type. Consumables dominate the market owing to the increase in the number of testing procedures, performed across research institutes, clinical labs and others. Instruments and software have also hold considerable shares in the global market owing to the technological advancement and product innovation, which have eased the entire process of medical research.

The fastest growing regional market is North America, due to the consistent growth in the M&A between the pharmaceutical and biotechnological companies, which have led to the expansion of the research field in the healthcare sector. Further, the sudden outbreak of COVID-19 is causing an adverse disruption in the global population, augmenting the need for precise diagnostic as well as therapeutic option, which is expected to drive the growth of the global multiplex assays market during the forecasted period.

Scope of the report:

The report provides a comprehensive analysis of the global multiplex assays market.

The major regional markets (North America, Asia-Pacific, Europe, Latin America and Middle East & Africa) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Thermo Fisher Scientific, Becton, Dickson and Company (BD), BioMerieux, Bio-Rad Laboratories, Qiagen and Luminex Corporation) are also presented in detail.

Key Target Audience:

  • Multiplex Assays Kit Manufacturers
  • Medical Technology and Pharmaceutical Firms
  • End Users (pharma & biotech companies, research institutes, clinical labs and hospitals)
  • Investment Banks
  • Healthcare and Medical Consultants
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1. Introduction
  • 1.2. Difference Between Traditional Assay and Multiplex Assay
  • 1.3. Determinants of Successful Molecular Multiplexing
  • 1.4. Multiplexing Platforms
  • 1.5. The Future of Multiplex Assays

2. Impact of COVID-19

  • 2.1. Rise in Number of COVID-19 Test
  • 2.2. Growth in Government Spending on Healthcare
  • 2.3. Rise in Adoption of Artificial Intelligence in Healthcare
  • 2.4. Regional Impact

3. Global Market Analysis

  • 3.1. Global Multiplex Assays Market by Value
  • 3.2. Global Multiplex Assays Market Forecast by Value
  • 3.3. Global Multiplex Assays Market by Product
    • 3.3.1. Global Multiplex Assays Consumables Market by Value
    • 3.3.2. Global Multiplex Assays Consumables Market Forecast by Value
    • 3.3.3. Global Multiplex Assays Instruments Market by Value
    • 3.3.4. Global Multiplex Assays Instruments Market Forecast by Value
    • 3.3.5. Global Multiplex Assays Software Market by Value
    • 3.3.6. Global Multiplex Assays Software Market Forecast by Value
  • 3.4. Global Multiplex Assays Market by Application
    • 3.4.1. Global Multiplex Assays Research & Development Market by Value
    • 3.4.2. Global Multiplex Assays Research & Development Market Forecast by Value
    • 3.4.3. Global Multiplex Assays Clinical Diagnostics Market by Value
    • 3.4.4. Global Multiplex Assays Clinical Diagnostics Market Forecast by Value
    • 3.4.5. Global Multiplex Assays Companion Diagnostics Market by Value
    • 3.4.6. Global Multiplex Assays Companion Diagnostics Market Forecast by Value
  • 3.5. Global Multiplex Assays Market by End-Users
    • 3.5.1. Global P&B Companies Multiplex Assays Market by Value
    • 3.5.2. Global P&B Companies Multiplex Assays Market Forecast by Value
    • 3.5.3. Global Research Institutes Multiplex Assays Market by Value
    • 3.5.4. Global Research Institutes Multiplex Assays Market Forecast by Value
    • 3.5.5. Global Clinical Labs Multiplex Assays Market by Value
    • 3.5.6. Global Clinical Labs Multiplex Assays Market Forecast by Value
    • 3.5.7. Global Hospital Multiplex Assays Market by Value
    • 3.5.8. Global Hospital Multiplex Assays Market Forecast by Value
  • 3.6. Global Multiplex Assays Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Multiplex Assays Market by Value
    • 4.1.2. North America Multiplex Assays Market Forecast by Value
  • 4.2. Asia-Pacific
    • 4.2.1. Asia-Pacific Multiplex Assays Market by Value
    • 4.2.2. Asia-Pacific Multiplex Assays Market Forecast by Value
  • 4.3. Europe
    • 4.3.1. Europe Multiplex Assays Market by Value
    • 4.3.2. Europe Multiplex Assays Market Forecast by Value
  • 4.4. Latin America
    • 4.4.1. Latin America Multiplex Assays Market by Value
    • 4.4.2. Latin America Multiplex Assays Market Forecast by Value
  • 4.5. Middle East & Africa
    • 4.5.1. Middle East & Africa Multiplex Assays Market by Value
    • 4.5.2. Middle East & Africa Multiplex Assays Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Increasing Prevalence of HIV Infections
    • 5.1.2. Rising Incidences of New Cancer Cases
    • 5.1.3. Increasing Medical Technology R&D Spending
    • 5.1.4. Growth in Geriatric Population
    • 5.1.5. Upsurge in Healthcare Expenditures
    • 5.1.6. Rise of Multiplex Immunoassays in Drug Discovery
    • 5.1.7. Escalating Adoption of Companion Diagnostics
  • 5.2. Key Trends and Developments
    • 5.2.1. Accelerating Growth Rates of Infectious Diseases
    • 5.2.2. Growth in Pharmaceutical and Biotech Merger & Acquisition
    • 5.2.3. Monitoring of Biosimilar in Autoimmune Diseases
    • 5.2.4. Demand for Multiplexed Point-of-Care Tests (xPOCT)
  • 5.3. Challenges
    • 5.3.1. Dearth of Skilled Professionals
    • 5.3.2. High Investment Capital for Multiplex Assays
    • 5.3.3. Stringent Government Regulations

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Key Players - Revenue Comparison
    • 6.1.2. Key Players - R&D Expenditure Comparison
    • 6.1.3. Key Players - Market Capitalization Comparison

7. Company Profiles

  • 7.1. Thermo Fisher Scientific
    • 7.1.1. Financial Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Becton, Dickinson and Company (BD)
    • 7.2.1. Financial Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. BioMerieux
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Bio-Rad Laboratories
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies
  • 7.5. Qiagen
    • 7.5.1. Business Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Business Strategies
  • 7.6. Luminex Corporation
    • 7.6.1. Business Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Business Strategies

List of figures

  • Difference Between Traditional Assay and Multiplex Assay
  • Factors for the Rising Adoption of Multiplex Assays
  • Global Government Share on Health Spending (2019-2024)
  • Global Healthcare Artificial Intelligence (AI) Market Forecast (2017-2021)
  • Global Multiplex Assays Market by Value (2015-2019)
  • Global Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Product (2019)
  • Global Multiplex Assays Consumables Market by Value (2015-2019)
  • Global Multiplex Assays Consumables Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Instruments Market by Value (2015-2019)
  • Global Multiplex Assays Instruments Forecast by Value (2020-2024)
  • Global Multiplex Assays Software Market by Value (2015-2019)
  • Global Multiplex Assays Software Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Application (2019)
  • Global Multiplex Assays Research & Development Market by Value (2015-2019)
  • Global Multiplex Assays Research & Development Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Clinical Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Clinical Diagnostics Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Companion Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Companion Diagnostics Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by End-Users (2019)
  • Global P&B Companies Multiplex Assays Market by Value (2015-2019)
  • Global P&B Companies Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Research Institutes Multiplex Assays Market by Value (2015-2019)
  • Global Research Institutes Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Clinical Labs Multiplex Assays Market by Value (2015-2019)
  • Global Clinical Labs Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Hospital Multiplex Assays Market by Value (2015-2019)
  • Global Hospital Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Region (2019)
  • North America Multiplex Assays Market by Value (2015-2019)
  • North America Multiplex Assays Market Forecast by Value (2020-2024)
  • Asia-Pacific Multiplex Assays Market by Value (2015-2019)
  • Asia-Pacific Multiplex Assays Market Forecast by Value (2020-2024)
  • Europe Multiplex Assays Market by Value (2015-2019)
  • Europe Multiplex Assays Market Forecast by Value (2020-2024)
  • Latin America Multiplex Assays Market by Value (2015-2019)
  • Latin America Multiplex Assays Market Forecast by Value (2020-2024)
  • Middle East & Africa Multiplex Assays Market by Value (2015-2019)
  • Middle East & Africa Multiplex Assays Market Forecast by Value (2020-2024)
  • Global HIV Infected Population (2015-2019)
  • Global New Cases of Top Cancer Types (2019)
  • Global Medical Technology R&D Spending (2015-2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Pharmaceutical R&D Spending (2015-2019)
  • Global Growth Rate of Infectious Diseases Forecast (2017-2022)
  • Global Pharmaceutical and Biotech M&A (2015-2019)
  • Thermo Fisher Scientific Revenue and Net Income (2015-2019)
  • Thermo Fisher Scientific Revenue by Segments (2019)
  • Thermo Fisher Scientific Revenue by Regions (2019)
  • Becton, Dickinson and Company Revenue and Net Income (2015-2019)
  • Becton, Dickinson and Company Revenue by Segments (2019)
  • Becton, Dickinson and Company Revenue by Regions (2019)
  • BioMerieux Net Sales and Net Income (2015-2019)
  • BioMerieux Net Sales by Product Application (2019)
  • BioMerieux Net Sales by Regions (2019)
  • Bio-Rad Laboratories Net Sales and Net Income (2015-2019)
  • Bio-Rad Laboratories Net Sales by Segments (2019)
  • Bio-Rad Laboratories Net Sales by Regions (2019)
  • Qiagen Net Sales and Net Loss (Income) (2015-2019)
  • Qiagen Net Sales by Product Classes (2019)
  • Qiagen Net Sales by Regions (2019)
  • Luminex Corporation Total Revenue and Net Loss (Income) (2015-2019)
  • Luminex Corporation Total Revenue by Source (2019)
  • Luminex Corporation Total Revenue by Regions (2019)